Analysis of Revenues
Paying user area
Try for free
CVS Health Corp. pages available for free this week:
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Reportable Segments
- Enterprise Value to FCFF (EV/FCFF)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to CVS Health Corp. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
CVS Health Corp., income statement, revenues
US$ in millions
| 12 months ended: | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy | |||||||||||
| Front Store | |||||||||||
| Premiums | |||||||||||
| Other | |||||||||||
| Revenues from customers |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The annual revenue data reveals several key trends across various revenue streams over the five-year period ending on December 31, 2024.
- Pharmacy Revenue
- Pharmacy revenues demonstrate a generally upward trend from 2020 through 2023, increasing from approximately $171.3 billion to $223.5 billion. However, in 2024, a decline is observed as revenues fall to about $210.3 billion. Despite this dip, the overall growth compared to 2020 remains significant.
- Front Store Revenue
- Front Store revenues show consistent growth from 2020 to 2022, rising from $19.7 billion to $22.8 billion. A slight decrease occurs in 2023 and continues into 2024, where revenues decrease to approximately $21.5 billion. The fluctuations in Front Store revenue are less pronounced compared to Pharmacy revenue.
- Premiums
- Premium revenues exhibit robust and steady growth throughout the entire period. Starting at $69.4 billion in 2020, premiums increase annually, reaching $122.9 billion in 2024. This category represents one of the strongest upward trends, suggesting expanding business or increased pricing in this area.
- Other Revenues
- Other revenue sources fluctuate but display an overall upward trajectory. From $7.6 billion in 2020, the amount increases to $16.0 billion in 2024, including a notable jump between 2022 and 2024. This indicates diversifying income streams or growth in ancillary services.
- Total Revenues from Customers
- Total customer revenues consistently increase over the period, from approximately $268 billion in 2020 to $371 billion in 2024. The increments each year reflect combined growth trends across the segments, with the highest relative increases influenced by premiums and other revenue streams.
In summary, the data indicates strength in premiums and total revenues, with pharmacy revenues showing variability by 2024. Front Store revenues exhibit minor declines after an initial growth phase. Other revenues contribute to overall growth with notable increases in later years. The overall revenue profile suggests a broad diversification of income streams with a strong emphasis on premium-related income growth.